The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-α
Open accessAbstract
The transcription factor RUNX2 (Cbfa1/AML3/Pebp2alphaA) is a critical regulator of osteoblast differentiation. We investigated the effect of the inflammatory cytokine tumor necrosis factor alpha (TNF) on the expression of RUNX2 because TNF is known to inhibit differentiation of osteoblasts from pluripotent progenitor cells. TNF treatment of fetal calvaria precursor cells or MC3T3-E1 clonal pre-osteoblastic cells caused a dose-dependent suppression of RUNX2 steady state mRNA as measured by reverse transcription-PCR. The IC(50) for TNF inhibition was 0.6 ng/ml. TNF suppression of RUNX2 mRNA was confirmed using Northern analysis. The effect of TNF was studied using isoform-specific primers that flanked unique regions of two major RUNX2 isoforms. TNF suppressed expression of the mRNA coding for the shorter MRIPV isoform by >90% while inhibiting expression of the mRNA for the longer MASNS isoform by 50%. RUNX2 nuclear content was evaluated by electrophoretic mobility shift assay using a rat osteocalcin promoter binding sequence as probe and by Western analysis. TNF reduced nuclear RUNX2 protein. Inhibition of new protein synthesis with cycloheximide failed to prevent TNF inhibition of RUNX2 mRNA, suggesting that a newly translated protein did not mediate the TNF effect. RUNX2 mRNA half-life was 1.8 h and reduced to 0.9 h by TNF. The effect of TNF on RUNX2 gene transcription was evaluated using a 0.6-kb RUNX2 promoter-luciferase reporter in MC3T3-E1 cells. TNF caused a dose-dependent inhibition of transcription to 50% of control values. The inhibitory effect of TNF was preserved with deletions to nucleotide -108 upstream of the translational start site; however, localization downstream of nucleotide -108 was obscured by loss of basal activity. Our results indicate that TNF regulates RUNX2 expression at multiple levels including destabilization of mRNA and suppression of transcription. The disproportionate inhibition of RUNX2 nuclear protein suggests that additional post-transcriptional mechanisms may be occurring. Suppression of RUNX2 by TNF may decrease osteoblast differentiation and inhibit bone formation in TNF excess states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80259-7 · Cited by 2,814
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
Lee, K.-S., Kim, H.-J., Li, Q.-L., Chi, X.-Z., Ueta, C., Komori, T., Wozney, J. M., Kim, E.-G., Choi, J.-Y., Ryoo, H.-M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8783-8792.2000 · Cited by 865
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., & Karsenty, G. (1999) · Genes & Development · doi:10.1101/gad.13.8.1025 · Cited by 774
Wang, D., Christensen, K., Chawla, K., Xiao, G., Krebsbach, P. H., & Dr. Franceschi, R. T. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.893 · Cited by 664
Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α*
Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J., & Nanes, M. S. (2000) · Endocrinology · doi:10.1210/endo.141.11.7739 · Cited by 555
Self-citationPacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
CBFA1: A molecular switch in osteoblast biology
Ducy, P. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1074>3.0.co;2-c · Cited by 446
Advances in the osteoblast lineage
Aubin, J. E. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-6-899 · Cited by 444
Banerjee, C., McCabe, L. R., Choi, J.-Y., Hiebert, S. W., Stein, J. L., Stein, G. S., & Lian, J. B. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970701)66:1<1::aid-jcb1>3.0.co;2-v · Cited by 438
Self-citationAmmann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., & Garcia, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119333 · Cited by 310
Gori, F., Thomas, T., Hicok, K. C., Spelsberg, T. C., & Riggs, B. L. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1522 · Cited by 294
Narayanan, K., Srinivas, R., Ramachandran, A., Hao, J., Quinn, B., & George, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081075198 · Cited by 276
Lee, M. H., Javed, A., Kim, H. J., Shin, H. I., Gutierrez, S., Choi, J. Y., Rosen, V., Stein, J. L., van Wijnen, A. J., Stein, G. S., et al. (1999) · PubMed · doi:10.1002/(sici)1097-4644(19990401)73:1&lt;114::aid-jcb13&gt;3.0.co;2-m · Cited by 254
Self-citationPathogenesis of bone erosions in rheumatoid arthritis
Goldring, S. R., & Gravallese, E. M. (2000) · Current Opinion in Rheumatology · doi:10.1097/00002281-200005000-00006 · Cited by 249
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene
Drissi, H., Luc, Q., Shakoori, R., Chuva De Sousa Lopes, S., Choi, J.-Y., Terry, A., Hu, M., Jones, S., Neil, J. C., Lian, J. B., et al. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<341::aid-jcp8>3.0.co;2-z · Cited by 247
Self-citationThe Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241
Aggarwal, B. B. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i6 · Cited by 235
Ralston, S. H., Russell, R. G. G., & Gowen, M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050912 · Cited by 231
Zhou, G., Chen, Y., Zhou, L., Thirunavukkarasu, K., Hecht, J., Chitayat, D., Gelb, B. D., Pirinen, S., Berry, S. A., Greenberg, C. R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2311 · Cited by 221
Stewart, M., Terry, A., Hu, M., O’Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., & Neil, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8646 · Cited by 216
Banerjee, C. (2001) · Endocrinology · doi:10.1210/en.142.9.4026 · Cited by 206
Selvamurugan, N., Pulumati, M. R., Tyson, D. R., & Partridge, N. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5037 · Cited by 188
Prince, M., Banerjee, C., Javed, A., Green, J., Lian, J. B., Stein, G. S., Bodine, P. V. N., & Komm, B. S. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010301)80:3<424::aid-jcb160>3.0.co;2-6 · Cited by 185
Self-citationThirunavukkarasu, K., Halladay, D. L., Miles, R. R., Yang, X., Galvin, R. J. S., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000322200 · Cited by 184
Javed, A., Barnes, G. L., Jasanya, B. O., Stein, J. L., Gerstenfeld, L., Lian, J. B., & Stein, G. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2891-2905.2001 · Cited by 177
Self-citationGenomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor
Xiao, Z., Thomas, R. F., Hinson, T. K., & Quarles, L. D. (1998) · Gene · doi:10.1016/s0378-1119(98)00227-3 · Cited by 156
Cbfa1 as a regulator of osteoblast differentiation and function
Karsenty, G., Ducy, P. F., Starbuck, M. W., Priemel, M., Shen, J. J., Geoffroy, V., & Amling, M. (1999) · Bone · doi:10.1016/s8756-3282(99)00111-8 · Cited by 134
Tsuji, K., Ito, Y., & Noda, M. (1998) · Bone · doi:10.1016/s8756-3282(97)00267-6 · Cited by 134
Komori, T., & Kishimoto, T. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80123-8 · Cited by 134
Effects of Tumor Necrosis Factor on Bone Formationin Vitro*
CANALIS, E. M. (1987) · Endocrinology · doi:10.1210/endo-121-5-1596 · Cited by 133
McCarthy, T. L., & CANALIS, E. M. (1988) · Endocrinology · doi:10.1210/endo-123-3-1442 · Cited by 122
Boden, S. D., Hair, G. A., Titus, L., Racine, M., McCuaig, K. A., Wozney, J. M., & Nanes, M. S. (1997) · Endocrinology · doi:10.1210/en.138.7.2820 · Cited by 120
Self-citationBoden, S. D., McCuaig, K. A., Hair, G., Racine, M., Titus, L., Wozney, J. M., & Nanes, M. S. (1996) · Endocrinology · doi:10.1210/en.137.8.3401 · Cited by 100
Self-citationNanes, M. S., McKoy, W. M., & Marx, S. J. (1989) · Endocrinology · doi:10.1210/endo-124-1-339 · Cited by 81
Self-citationSchinke, T., & Karsenty, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30182 · Cited by 73
Vicini, P., & Kushmerick, M. J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.1.c213 · Cited by 65
Nanes, M. S., Rubin, J. E., Titus, L., Hendy, G. N., & Catherwood, B. D. (1991) · Endocrinology · doi:10.1210/endo-128-5-2577 · Cited by 63
Self-citationKuno, H., Kurian, S., Hendy, G. N., White, J. L., DeLuca, H. F., Evans, C. O., & Nanes, M. S. (1994) · Endocrinology · doi:10.1210/endo.134.6.8194478 · Cited by 53
Self-citationOgawa, S. (2000) · DNA Research · doi:10.1093/dnares/7.3.181 · Cited by 37
Identification and Expression of a Novel 3′-Exon of Mouse Runx1/Pebp2αB/Cbfa2/AML1 Gene
Tsuji, K., & Noda, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3112 · Cited by 24
Cited by
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Role and regulation of RUNX2 in osteogenesis
AO Research Institute Davos, C. 8., Bruderer, M., Richards, R., Alini, M., & Stoddart, M. (2014) · European Cells and Materials · doi:10.22203/ecm.v028a19 · Cited by 583
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
A crucial role for thiol antioxidants in estrogen-deficiency bone loss
Lean, J. M., Davies, J. T., Fuller, K., Jagger, C. J., Kirstein, B., Partington, G. A., Urry, Z., & Chambers, T. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18859 · Cited by 547
Metadata
- Authors
- Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., van Wijnen, A. J., Lian, J. B., Stein, G. S., & Nanes, M. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 4
- Pages
- 2695-2701
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2085627522
- Cited by
- 443
- References
- 45
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.